Astraea
YC X26San Francisco, US · Founded 2026 · 2 employees · 1 known investors
Astraea provides clinical trial automation software for pharmaceutical sponsors that uses AI to automate post-protocol tasks including statistical analysis plans, case report forms, datasets, regulatory documentation, and FDA submissions. The platform is deployed within the sponsor's own environment to maintain data security and compliance across oncology, rare disease, and medical devices.
Founders & leadership· Y Combinator alumni (X26)
Joshua Wangin𝕏Founder
Sanmay SaradainFounder
Investors · 1
In the news
- How to Start a Venture Fund: The Complete Decision Guide | Astraea Counselastraea.law · 2026
- Astraea - 2026 Company Profile, Team & Competitors - Tracxntracxn.com · 2026
- Richmond Inno - Charlottesville's Astraea looks to scale up with new fundingbizjournals.com · 2022
- Astrea Raises $6.5M Series A from Climate-Focused VCs - Via Satellitesatellitetoday.com · 2022
- Astraea Raises $6.5M Series A Funding - FinSMEsfinsmes.com · 2022
- Astraea raises $6.5M for satellite monitoring of renewables, carbon programsaxios.com · 2022